Target intelligence / Profile preview

Bone hydroxyapatite (HA)

Target
HA
Molecular classification
Inorganic mineral, Bone matrix component, Other
01

Overview

Bone hydroxyapatite is the primary inorganic mineral component of bone and teeth, consisting of a crystalline calcium phosphate matrix with the chemical formula Ca10(PO4)6(OH)2. It provides structural rigidity, compressive strength, and mechanical support to the skeletal system, while also serving as a reservoir for calcium and phosphate ions to maintain systemic mineral homeostasis. In pharmacological contexts, the bone hydroxyapatite surface is a critical therapeutic target for bone-targeting drugs, particularly bisphosphonates and bone-seeking radiopharmaceuticals. Bisphosphonates, such as alendronate and zoledronic acid, bind avidly to hydroxyapatite crystals at sites of active bone remodeling. Upon osteoclast-mediated bone resorption, the local acidic environment dissolves the mineral matrix, releasing the drugs to be internalized by osteoclasts, where they inhibit key metabolic pathways and induce apoptosis to prevent bone loss. Additionally, bone-seeking radiopharmaceuticals like radium-223 and samarium-153 target hydroxyapatite to deliver localized cytotoxic radiation to bone metastases, making this mineral surface a cornerstone for treating osteoporosis, Paget's disease, and skeletal malignancies.

Other names
Bone mineralBone mineral matrixHydroxyapatite matrixCalcium-phosphate mineral surfaceHydroxylapatiteBone hydroxyapatite matrixCalcium phosphate tribasic
02

Mechanism of action

Bisphosphonates bind with high affinity to bone hydroxyapatite crystals, particularly at sites of active bone remodeling. During osteoclast-mediated bone resorption, the local acidic environment dissolves the hydroxyapatite mineral, releasing the bisphosphonates. The released drugs are internalized by osteoclasts via fluid-phase endocytosis, where they inhibit farnesyl pyrophosphate synthase (nitrogen-containing bisphosphonates) or form cytotoxic ATP analogs (non-nitrogen-containing bisphosphonates), ultimately inducing osteoclast apoptosis and reducing bone resorption. Bone-seeking radiopharmaceuticals mimic calcium or bind directly to hydroxyapatite, delivering localized ionizing radiation to destroy cancer cells in bone metastases.

03

Biological functions

Bone mineralizationMineral ion homeostasisStructural supportOsteoconductionOsteointegrationCell anchorage
04

Disease associations

OsteoporosisPaget's disease of boneBone metastasisOsteosarcomaHypercalcemia of malignancyBone fractureOsteopenia
05

Safety considerations

Osteonecrosis of the jaw (ONJ)Atypical femoral fracture (AFF)HypocalcemiaSevere musculoskeletal painRenal toxicityGastrointestinal irritation and esophagitisMyelosuppression
06

Interacting drugs

11 more in the full profile.

07

Biomarkers

Bone mineral density (BMD)Serum bone-specific alkaline phosphatase (BSAP)Urinary N-telopeptide of type I collagen (NTx)Serum C-telopeptide of type I collagen (CTx)Serum osteocalcinUrinary deoxypyridinoline (DPD)

Beyond the preview

Go deeper on Bone hydroxyapatite (HA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bone hydroxyapatite (HA).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call